New clinical studies are being conducted throughout the U.S. to evaluate the safety and efficacy of Alista™, a topically applied product for the treatment of women with female sexual arousal disorder (FSAD) as a result of undergoing a hysterectomy. As there are no medications currently approved by the FDA for the treatment of diminished sexual arousal, these clinical studies are an important step in the development of new therapeutic options to provide women with useful treatments for decreased sexual arousal.
-- Checking In - Feel Great - Lose Weight The HysterSisters January 'Checking In' eMagazine has been published and should be in your email inbox if you are a regi [More]...